ScienceDaily reports that an existing drug – having passed FDA regulations for sale as a cosmetic product over five years ago – may have a powerful effect in regrowing hair.
Bimatoprost is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. We have discussed prostaglandins and their major role in hair loss and regrowth many times, and feel that this study lends further validation to our findings.
In December 2008, the FDA also approved the drug for the cosmetic application of lengthening eyelashes, currently sold under the trade name Latisse. The manufacturer realized this application upon observing that one of the drug’s side effects (when used as Glaucoma medicine) was a thickening of the eyelashes.
While the study is just one step towards an actual, tangible, usable product with a scalp-delievery system, it likely highlights what we have covered numerous times on our site and in our eBook, Ultimate Hair Secrets – prostaglandins are a major component of hair loss and may be more key to successful hair regrowth than systematic DHT blockers.
To learn more about the truth behind hair loss, including prostaglandins, and the natural way to induce prostaglandin inhibition systemically and topically, along with balancing overall hormonal health for optimal hair regrowth, please learn more in our eBook, Ultimate Hair Secrets.